Conference Agenda

 

Keynote and Plenary Session
Biopharma Industry Overview and Future Evolution | Disruptive Innovation and the Way ForwardRegulatory Updates and Strategies to Fast-Track the Launch of Biopharmaceuticals Drugs
NETWORKING REFRESHMENTS & VISIT to EXHIBITION
TRACKS
Biologics Biosimilars Vaccines Biomanufacturing/Immunotherapy
Biologics Global Launch Strategies and Future Opportunities Globally Biosimilars: FDA Guideline Released in May 2019 WHO PQ Inspection Experience of Vaccines Manufacturers: Data Integrity Issues and WHO’s Expectations Current Challenges and Opportunities in Biomanufacturing
Regulatory Updates in the Developing Novel Biologics WHO Prequalification Process of Biosimilars Global Vaccines Outlook Immunogenicity
NETWORKING LUNCH & VISIT to EXHIBITION
R&D and Manufacturing of Biologics Biosimilars Global Market Action Plan and Future Opportunities Current Regulatory Framework and Recent Updates to Optimize the Vaccines Development Process Immunotherapy Trends in the Global Arena
Continuous Processing for Biosimilars Manufacturing
Clinical Trial and Clinical Development Manufacturing: Upstream and Downstream Processes Vaccines Delivery Platforms Cell Line Development and Cell- Culture Engineering
Marketing and Commercialization Strategies to Ensure Brand Development Next-Generation Vaccines Streamline Scale-up and Technology Transfer
NETWORKING HIGH-TEA & VISIT to EXHIBITION
Protecting the Innovation Sailing Through Complexities of Biosimilars Clinical Trial Development cGMP Practices and Technological Advancements to Develop Cost-Effective Vaccines Quality as a Culture: Incorporating Process Analytical Techniques (PAT) and Quality by Design (QbD) to Improvise Quality Assurance and Reduce Timelines
Business Licensing and Alliances Vaccines Bioprocessing and Manufacturing
CLOSING REMARKS BY THE CHAIRPERSON
NETWORKING AND END OF CONFERENCE

 

Gene Therapy Biosimilars Vaccines Biomanufacturing/Immunotherapy
Recent Advances in Cell and Gene Therapy cGMP Manufacturing Requirements and Challenges – A Global Perspective Navigating Through the Complexities of Clinical Development for Vaccines Digitalisation and Newer Strategies for Biopharmaceutical Manufacturing
Cost-effective Strategies for Vaccines Development
Technology Transfer Systems Human Vaccines against Infectious Diseases
NETWORKING REFRESHMENTS & VISIT to EXHIBITION
Evolution and Manufacturing Efficient of Gene Transfer Vectors Global Development Strategy on Biosimilars: How to Win in the International Space Highlights of Latest Technologies in Vaccines Continuous Manufacturing: The Global Mantra
Bio-betters Immunization and Innovations in Vaccines Evolution Pharma 4.0 Manufacturing and Supply Chain
NETWORKING LUNCH & VISIT to EXHIBITION
Orphan Diseases Corporate Alliances to Ensure Successful Launch of Biosimilars Commercialization and Marketing Strategies to Successfully Launch Cost-Effective Vaccines Across the Globe Supply Chain Management Strategies – Introducing Products Reliably, Efficiently and Cost Effectively to the Market
The Technological Paradigm Shift: CAR-T Therapy External Alliances
NETWORKING HIGH-TEA & VISIT to EXHIBITION
CRISPR Technology Intellectual Property Rights of Biosimilars Patent Filing and Protecting your Launch Utilizing Latest Strategies and Techniques to Optimize Biomanufacturing in a Cost-Effective Way
Marketing of Biosimilars: Commodity versus Differentiated
Immuno-Oncology Commercialization: Managing Costs and Technology Adoption Strategies to Overcome Challenges and the Competitive Market
CLOSING REMARKS BY THE CHAIRPERSON
NETWORKING AND END OF CONFERENCE